2
Case 1:14-cv-01364-GMS Document 90 Filed 09/29/16 Page 1 of 2 PagelD #: 1687 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE RECRO GAINESVILLE LLC, ) ) Plaintiff, ) ) v. ) C.A. No. 14-1364 (GMS) ) ALVOGEN MALTA OPERATIONS LTD., ) ) Defendant. ) STIPULATION OF DISMISSAL Pursuant to Rules 41(a)(l)(A)(ii) and 41(c) of the Federal Rules of Civil Procedure, Plaintiff and Defendant hereby stipulate and agree that the above action, including all claims, counterclaims, and affirmative defenses, are dismissed without prejudice, and without costs, disbursements, or attorneys' fees to any party. Nothing herein shall prohibit or restrict Defendant from maintaining or filing Paragraph IV certifications in ANDA No. 206986=under 21 U.S.C. § 355U)(2)(A)(vii)(IV) (as amended or supplemented) and nothing herein shall prohibit or restrict the Food and Drug Administration from reviewing or approving ANDA No. 206986. MORRIS, NICHOLS, ARSHT & TUNNELL LLP Maryellen Noreika Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) Jeremy A. Tigan (#5239) Megan E. Dellinger (#5739) 1201 North Market Street Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] [email protected] [email protected] Attorneys for Plaintiff SHAW KELLER LLP DavidM Fry Karen E. Keller (#4489) David M. Fry (#5486) 300 Delaware Avenue Suite 1120 Wilmington, DE 19801 (302) 298-0700 [email protected] [email protected] Attorneys for Defendant Case 1:14-cv-01364-GMS Document 91 Filed 09/30/16 Page 1 of 2 PageID #: 1689

Recro vs alvogen_case_conclusion Case 1:14-cv-01364

Embed Size (px)

Citation preview

Page 1: Recro vs alvogen_case_conclusion Case 1:14-cv-01364

Case 1:14-cv-01364-GMS Document 90 Filed 09/29/16 Page 1 of 2 PagelD #: 1687

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

RECRO GAINESVILLE LLC, ) )

Plaintiff, ) )

v. ) C.A. No. 14-1364 (GMS) )

ALVOGEN MALTA OPERATIONS LTD., ) )

Defendant. )

STIPULATION OF DISMISSAL

Pursuant to Rules 41(a)(l)(A)(ii) and 41(c) of the Federal Rules of Civil Procedure,

Plaintiff and Defendant hereby stipulate and agree that the above action, including all claims,

counterclaims, and affirmative defenses, are dismissed without prejudice, and without costs,

disbursements, or attorneys' fees to any party. Nothing herein shall prohibit or restrict

Defendant from maintaining or filing Paragraph IV certifications in ANDA No. 206986=under 21

U.S.C. § 355U)(2)(A)(vii)(IV) (as amended or supplemented) and nothing herein shall prohibit

or restrict the Food and Drug Administration from reviewing or approving ANDA No. 206986.

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

Maryellen Noreika

Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) Jeremy A. Tigan (#5239) Megan E. Dellinger (#5739) 1201 North Market Street Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] [email protected] [email protected]

Attorneys for Plaintiff

SHAW KELLER LLP

DavidM Fry

Karen E. Keller (#4489) David M. Fry (#5486) 300 Delaware Avenue Suite 1120 Wilmington, DE 19801 (302) 298-0700 [email protected] [email protected]

Attorneys for Defendant

Case 1:14-cv-01364-GMS Document 91 Filed 09/30/16 Page 1 of 2 PageID #: 1689

Page 2: Recro vs alvogen_case_conclusion Case 1:14-cv-01364

Case 1:14-cv-01364-GMS Document 90 Filed 09/29/16 Page 2 of 2 PagelD #: 1688

OF COUNSEL:

Chad A. Landman Matthew J. Becker AXINN, VELTROP & HARKRIDER LLP 90 State House Square Hartford, CT 06103-3702 (860) 2 7 5-8100

Seth I. Heller AXINN, VELTROP & HARKRIDER LLP 950 F Street, N.W. Washington, DC 20004 (202) 912-4700

September 29, 2016 rt. SO ORDERED this°;? day of _~o------+----

Case 1:14-cv-01364-GMS Document 91 Filed 09/30/16 Page 2 of 2 PageID #: 1690